Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

42.73
Delayed Data
As of 4:01pm ET
 +0.32 / +0.75%
Today’s Change
37.20
Today|||52-Week Range
45.58
+10.96%
Year-to-Date
VBI Vaccines Emerges as Strong Biotech Stock
4:04pm / TheStreet.com - Paid Partner Content
Pernix: An Investor's Rationale to Staying Long
Mar 23 / GuruFocus News - Paid Partner Content
GlaxoSmithKline Continues to Strengthen
3:17pm / TheStreet.com - Paid Partner Content
Novartis' Acute Heart Failure Drug Fails in Late-Stage Study
Mar 22 / Zacks.com - Paid Partner Content
J&J (JNJ) Anaemia Drug Marketing Label Expanded in Europe
Mar 27 / Zacks.com - Paid Partner Content
Jeff Auxier Reduces, Exits Multiple Positions in 4th Quarter
Mar 22 / GuruFocus News - Paid Partner Content
Merck's Ketruda Gets Positive CHMP Opinion for Lymphoma
Mar 27 / Zacks.com - Paid Partner Content
Allergan's Dermal Filler for Wrinkle Correction Gets FDA Nod
Mar 21 / Zacks.com - Paid Partner Content
Why Google Has to Definitively Address Its Offensive Content Problem
Mar 23 / TheStreet.com - Paid Partner Content
6 Reasons to Invest in GlaxoSmithKline (GSK) Stock in 2017
Mar 21 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close42.41
Today’s open42.17
Day’s range42.15 - 42.77
Volume4,902,393
Average volume (3 months)3,561,995
Market cap$104.3B
Dividend yield4.70%
Data as of 4:01pm ET, 03/29/2017

Growth & Valuation

Earnings growth (last year)-90.48%
Earnings growth (this year)+8.59%
Earnings growth (next 5 years)+11.22%
Revenue growth (last year)+2.85%
P/E ratio114.9
Price/Sales2.52
Price/Book74.31

Competitors

 Today’s
change
Today’s
% change
ABBVAbbVie-0.21-0.32%
CELGCelgene-0.34-0.27%
LLYEli Lilly and Co-0.31-0.37%
BMYBristol-Myers Squibb-0.25-0.44%
Data as of 4:02pm ET, 03/29/2017

Financials

Next reporting dateApril 26, 2017
EPS forecast (this quarter)$0.64
Annual revenue (last year)$37.5B
Annual profit (last year)$1.2B
Net profit margin3.27%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Andrew Philip Witty
Chief Financial Officer &
Executive Director
Simon Dingemans
Corporate headquarters
Brentford, Greater London

Forecasts


Search for Jobs